Sonic Healthcare Limited
SHL
Rang in Aktien
#2842
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Aktienkurs
$13.26
Marktkapitalisierung
$6.55B
Veränderung (1 Tag)
-0.21%
Veränderung (1 Jahr)
-4.48%
Land
AU
Handel Sonic Healthcare Limited (SHL)
Kategorie
Healthcare
P/S-Verhältnis für Sonic Healthcare Limited (SHL)
P/S-Verhältnis zum October 2026 TTM: 0.83
Laut den neuesten Finanzberichten und dem Aktienkurs von Sonic Healthcare Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0.83. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 1.37.
P/S-Verlauf für Sonic Healthcare Limited von 2000 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 0.83 | -37.72% |
| 2025 | 1.34 | -2.23% |
| 2024 | 1.37 | -33.35% |
| 2023 | 2.05 | 20.96% |
| 2022 | 1.70 | -19.02% |
| 2021 | 2.09 | -4.87% |
| 2020 | 2.20 | 10.87% |
| 2019 | 1.99 | 5.00% |
| 2018 | 1.89 | -5.30% |
| 2017 | 2.00 | 11.72% |
| 2016 | 1.79 | -13.70% |
| 2015 | 2.07 | 15.16% |
| 2014 | 1.80 | 7.74% |
| 2013 | 1.67 | 12.05% |
| 2012 | 1.49 | -8.11% |
| 2011 | 1.62 | 19.07% |
| 2010 | 1.36 | -10.17% |
| 2009 | 1.52 | -25.67% |
| 2008 | 2.04 | -15.85% |
| 2007 | 2.42 | -3.55% |
| 2006 | 2.51 | -0.02% |
| 2005 | 2.51 | 6.29% |
| 2004 | 2.36 | 35.28% |
| 2003 | 1.75 | 25.47% |
| 2002 | 1.39 | -44.99% |
| 2001 | 2.53 | 0.00% |
| 2000 | 0.00 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 5.37 | 543.65% |
US
|
|
| 6.29 | 653.91% |
US
|
|
| 21.02 | 2,418.49% |
US
|
|
| - | - |
CN
|
|
| 6.67 | 698.73% |
US
|
